17.09.2010
- Sanofi-Aventis sees a reasonable chance of buying U.S. biotech Genzyme at a fair price, but expects it will take some time to agree a deal that would further diversify the French...
17.09.2010
- Genzyme said it expects a broad cost-cutting program that includes laying off 1,000 employees over 15 months will boost profitability and allow it to invest in areas crucial to its...
13.09.2010
- French drugmaker Sanofi-Aventis poured cold water on a report it had raised its offer for U.S. biotechnology company Genzyme, saying it was sticking to its bid of $18.5 billion or...
13.09.2010
- French drugmaker Sanofi-Aventis has put together about $10 billion in loans for its $18.5 billion bid for U.S. biotech company Genzyme, Bloomberg reported on Friday, citing unnamed...
08.09.2010
- Sanofi-Aventis Chief Executive Chris Viehbacher has stepped up his campaign to win Genzyme by meeting shareholders of the U.S. biotech company face to face, the French company said...
06.09.2010
- French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a...
02.09.2010
- U.S. biotech Genzyme, which has rejected an $18.5 billion offer from French drugmaker Sanofi-Aventis, appears to hold the upper hand in the takeover struggle, according to Geoffrey...
02.09.2010
- French oil company Total has received offers for its UK Lindsey refinery and hopes to sell it by the end of the year, Chief Executive Officer Christophe de Margerie, said on...
